Navigation Links
Receiving chemotherapy after a breast cancer diagnosis may affect a patient's employment
Date:4/27/2014

A new study has found that loss of paid employment after a diagnosis of early-stage breast cancer may be common and potentially related to the type of treatment patients received. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings support efforts to reduce the side effects and burden of treatments for breast cancer and to identify patients who may forego certain treatments, particularly when the expected benefit is low.

Many women with early-stage breast cancer are working at the time of diagnosis and survive without cancer recurrence. Therefore, it's important to understand the impacts of chemotherapy on early-stage breast cancer survivors' employment. Reshma Jagsi, MD, of the University of Michigan Health System, and her colleagues studied 2290 women in the Los Angeles and Detroit areas who were diagnosed with nonmetastatic breast cancer between 2005 and 2007 and who completed surveys soon after diagnosis; 1536 of the women also completed a four-year follow-up questionnaire.

Of the 1026 patients under age 65 at diagnosis whose breast cancer did not recur and who responded to both surveys, 746 (76 percent) worked for pay before diagnosis. Of these, 236 (30 percent) were no longer working at follow-up. Women who received chemotherapy as part of initial treatment were less likely to be working at the four-year follow-up than women who were not treated with chemotherapy (38 percent vs 27 percent). Calculations showed that women who received chemotherapy at the time of diagnosis were 1.4-times more likely to be subsequently unemployed. Many women who were not employed after treatment wanted to work: 50 percent reported that it was important for them to work and 31 percent were actively seeking work.

"Many clinicians believe that although patients may miss work during treatment, they will 'bounce back' in the longer term. The results of this study suggest otherwise and highlight a possible long-term adverse consequence to adjuvant chemotherapy that may not have been fully appreciated to date," said Dr. Jagsi. She stressed the need to continue to develop strategies to identify patients who receive little benefit from chemotherapy and might be able to avoid it. "We also need to ensure that patients who are deciding on whether to receive chemotherapy understand the potential long-term consequences of receiving treatment, including possible implications for their employment and financial outcomes," she said.


'/>"/>

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
Wiley
Source:Eurekalert

Related medicine news :

1. Parents receiving heart disease diagnosis for infants need better information
2. More women receiving breast reconstruction after mastectomy, study finds
3. Patients receiving ADT should be counseled to improve mental and emotional well-being
4. Cine Learning's Online Story-based Leadership Courses Receiving Rave Reviews
5. US citizenship increases womens odds of receiving mammograms, cancer tests
6. Mayo-led study: Drug fails to reduce diarrhea in patients receiving radiation therapy
7. Swallowing exercises preserve function in head and neck cancer patients receiving radiation
8. Older Americans Not Receiving the Oral Health Care They Need
9. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offer Newly Designed hCG Diet Plans that Aid Patients in Receiving Improved Medical Care
10. Febe, a Scleroderma Patient, Starts New Life After Receiving a Stem Cell Treatment at World Stem Cells Clinic in Cancun
11. Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... SignatureCare Emergency Center – South Austin is treating ... Hours a day. , The Emergency Room opened early March, making ... four months now and things are running smoothly,” said Aaron Braun, SignatureCare Emergency Center’s ...
(Date:7/24/2017)... MO (PRWEB) , ... July 24, 2017 , ... ... acclaimed Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), part of Saint ... basis since 2016. , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins Stanley ...
(Date:7/24/2017)... ... July 24, 2017 , ... BayMark Health Services has ... Services Administration’s (SAMHSA) State Targeted Response to the Opioid Crisis program. The ... facilitate the development of a hub and spoke model for opioid treatment in ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... in scholarship awards to be awarded annually to and divided between two full-time ... in bringing awareness to Amazonian plant medicine. To apply for the scholarship, students ...
(Date:7/24/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... to expand its solution to help government contractors more quickly and cost-effectively comply ... to address the authentication requirements within NIST SP800-171, but no matter how you ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
(Date:7/10/2017)... -- The tenth annual BioPharm America™ will take ... the Sheraton Boston Hotel, September 26–27. The event will ... makers and innovative biotech startup companies. The event is ... impactful days. BioPharm America is now part of Biotech ... with 4,500+ life science industry influencers participating in 8+ ...
Breaking Medicine Technology: